<!--The Official Report of Parliamentary Debates (Hansard) of the Legislative Council and the House of Assembly of the Parliament of South Australia are covered by parliamentary privilege. Republication by others is not afforded the same protection and may result in exposure to legal liability if the material is defamatory. You may copy and make use of excerpts of proceedings where (1) you attribute the Parliament as the source, (2) you assume the risk of liability if the manner of your use is defamatory, (3) you do not use the material for the purpose of advertising, satire or ridicule, or to misrepresent members of Parliament, and (4) your use of the extracts is fair, accurate and not misleading. Copyright in the Official Report of Parliamentary Debates is held by the Attorney-General of South Australia.-->
<hansard id="" tocId="" xml:lang="EN-AU" schemaVersion="1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xml="http://www.w3.org/XML/1998/namespace" xmlns:xsi="http://www.w3.org/2007/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:noNamespaceSchemaLocation="hansard_1_0.xsd">
  <name>Legislative Council</name>
  <date date="2019-03-19" />
  <sessionName>Fifty-Fourth Parliament, First Session (54-1)</sessionName>
  <parliamentNum>54</parliamentNum>
  <sessionNum>1</sessionNum>
  <parliamentName>Parliament of South Australia</parliamentName>
  <house>Legislative Council</house>
  <venue></venue>
  <reviewStage>published</reviewStage>
  <startPage num="2855" />
  <endPage num="2903" />
  <dateModified time="2022-08-06T14:30:00+00:00" />
  <proceeding continued="true">
    <name>Question Time</name>
    <subject>
      <name>CBD Oil</name>
      <text id="2019031962d0e667b87a4acfb0000242">
        <heading>CBD Oil</heading>
      </text>
      <talker role="member" id="4363" kind="question">
        <name>The Hon. T.A. FRANKS</name>
        <house>Legislative Council</house>
        <questions>
          <question date="2019-03-19">
            <name>CBD Oil</name>
          </question>
        </questions>
        <startTime time="2019-03-19T15:36:38" />
        <text id="2019031962d0e667b87a4acfb0000243">
          <timeStamp time="2019-03-19T15:36:38" />
          <by role="member" id="4363">The Hon. T.A. FRANKS (15:36):</by>  My question is to the Minister for Health and Wellbeing, on the topic of CBD oil. Can the minister please clarify for patients, such as those who have contacted me, the legal status of CBD oil in South Australia?</text>
      </talker>
      <talker role="member" id="3164" kind="answer">
        <name>The Hon. S.G. WADE</name>
        <house>Legislative Council</house>
        <portfolios>
          <portfolio id="">
            <name>Minister for Health and Wellbeing</name>
          </portfolio>
        </portfolios>
        <questions>
          <question date="2019-03-19">
            <name>CBD Oil</name>
          </question>
        </questions>
        <startTime time="2019-03-19T15:36:57" />
        <text id="2019031962d0e667b87a4acfb0000244">
          <timeStamp time="2019-03-19T15:36:57" />
          <by role="member" id="3164">The Hon. S.G. WADE (Minister for Health and Wellbeing) (15:36):</by>  I thank the honourable member for her question. I am advised that cannabidiol—or CBD, as it is commonly known—is legally available as a schedule 4, that is, as a prescription-only medicine, in South Australia. This follows a decision by the commonwealth therapeutic goods authority, which took effect nationally in July 2015.</text>
        <text id="2019031962d0e667b87a4acfb0000245">At present, there are no registered or approved CBD products marketed for use in Australia. To enable timely access for patients, there are, however, a number of importers licensed by the commonwealth Office of Drug Control to import CBD medicines and several businesses licensed to manufacture CBD medicines in Australia. As there are no registered CBD medicines at this time in Australia, access and approval to prescribe these products is through the TGA Special Access Scheme, the Authorised Prescriber Scheme or through clinical trials.</text>
        <text id="2019031962d0e667b87a4acfb0000246">More information on accessing medicinal cannabis products, including CBD oil, is available on the TGA website and also on the SA Health website. There is no authorisation required under South Australia's controlled substances legislation for a doctor to prescribe a schedule 4 medicine, including a schedule 4 CBD product. Doctors wanting more information about the clinical use of, and access to, CBD can contact the SA Health Medicines Information Service or the TGA. Contact details for the businesses that are approved to import and supply cannabis and CBD medicines are publicly available on the ODC website.</text>
      </talker>
    </subject>
  </proceeding>
</hansard>